Understanding of the Indian pharmaceuticals market: understanding of the financial methods of valuation such as DCF, peer trading comparison; Investment banking: JP Morgan

The Digital Institutional Repository of IIM Bangalore

Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/2074/8108

DC Field	Value	Language
dc.contributor.author	Mittal, Akanksha
dc.date.accessioned	2019-07-02T09:52:43Z	-
dc.date.available	2019-07-02T09:52:43Z	-
dc.date.issued	2014
dc.identifier.uri	http://repository.iimb.ac.in/handle/2074/8108	-
dc.description.abstract	As a part of my summer internship project with the Investment Banking Division of JP Morgan, I was asked to present a fairness opinion to the Board of Daiichi Sankyo on the recent acquisition of Ranbaxy Laboratories by Sun Pharmaceutical Industries Limited for a consideration of US$4 bn. The presentation was made to the internal team of JP Morgan as a part of the screening process.
dc.publisher	Indian Institute of Management Bangalore
dc.relation.ispartofseries	PGP-SP-P14-035
dc.subject	Investment banking; Banking; Pharmaceutics
dc.title	Understanding of the Indian pharmaceuticals market: understanding of the financial methods of valuation such as DCF, peer trading comparison; Investment banking: JP Morgan
dc.type	Summer Project Report-PGP
dc.pages	4p.
Appears in Collections:	2014

File	Size	Format
PGP_SP_P14_035.pdf	54.14 kB	Adobe PDF	View/Open Request a copy

Check